Consolidated Statement of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities
Net income including noncontrolling interest	$ 5,248	$ 4,589
Adjustments to reconcile net income including noncontrolling interest to net cash provided by operating activities
Depreciation and amortization	1,371	1,408
Company pension and postretirement contributions	(102)	(121)
Company pension and postretirement expense	124	137
Stock-based compensation expense	226	227
Gain on business divestitures	(2,724)	0
Deferred income taxes	(495)	(155)
Changes in assets and liabilities
Accounts receivable	(467)	(324)
Inventories	(1,018)	(823)
Accounts payable	175	340
Accrued income taxes (current and long-term)	(11)	(41)
Other — net	1,342	212
Net cash provided by (used in) operating activities	3,669	5,449
Cash Flows from Investing Activities
Purchases of property, plant and equipment (PP&E)	(1,243)	(1,047)
Proceeds from sale of PP&E and other assets	65	44
Purchases of marketable securities and investments	(840)	(1,810)
Proceeds from maturities and sale of marketable securities and investments	868	1,363
Proceeds from sale of businesses, net of cash sold	13	0
Cash payment from Food Safety business split-off, net of divested cash	478	0
Other — net	1	18
Net cash provided by (used in) investing activities	(658)	(1,432)
Cash Flows from Financing Activities
Change in short-term debt — net	340	4
Repayment of debt (maturities greater than 90 days)	(1,179)	(450)
Proceeds from debt (maturities greater than 90 days)	1	1
Purchases of treasury stock	(928)	(1,261)
Proceeds from issuance of treasury stock pursuant to stock option and benefit plans	310	566
Dividends paid to shareholders	(2,550)	(2,572)
Other — net	(29)	(21)
Net cash provided by (used in) financing activities	(4,035)	(3,733)
Effect of exchange rate changes on cash and cash equivalents	(136)	(40)
Net increase (decrease) in cash and cash equivalents	(1,160)	244
Cash and cash equivalents at beginning of year	4,564	4,634
Cash and cash equivalents at end of period	$ 3,404	$ 4,878